SCHEMBL5821998

SCHEMBL5821998

O=S(=O)(O)C(CCCOCCCC(S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28688857 0.81 TP53 (0.37)
SCHEMBL30477999 0.79 TSHR (0.33)
SCHEMBL28119426 0.73 TSHR (0.32)
SCHEMBL462373 0.72 TP53 (0.46)
SCHEMBL27714617 0.72 CA1 (0.31)
SCHEMBL6632566 0.72
SCHEMBL7108948 0.72 APP (0.46)
SCHEMBL1270580 0.70 TP53 (0.56)
SCHEMBL27694688 0.70 CA1 (0.30)
SCHEMBL31081803 0.70 TP53 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889056-B1 Process for making a cyclodextrin PFIZER PROD INC (US) 2006-04-12 EP disclosed
US-6153746-A TREATING AN UNSUBSTITUTED CYCLODEXTRIN STARTING MATERIAL WITH AN ALKYL SULTONE IN THE PRESENCE OF A BASE, THE BASE IS ADDED IN A STEPWISE, PH CONTROLLED MANNER PFIZER INC. (US) 2000-11-28 US disclosed
EP-0889056-A2 Process for making a cyclodextrin Pfizer Products Inc. (US) 1999-01-07 EP disclosed